Showing 471-480 of 2792 results for "".
Navigating the LGMD2I/R9 Diagnostic Pathway
https://practicalneurology.com/programs/cme/navigating-the-lgmd2ir9-diagnostic-pathway/35879/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Advancing Care: Clinical Innovations on the Horizon
https://practicalneurology.com/programs/cme/advancing-care-clinical-innovations-on-the-horizon/35881/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.The Role of Multidisciplinary Care in LGMD2I/R9
https://practicalneurology.com/programs/cme/the-role-of-multidisciplinary-care-in-lgmd2ir9/35880/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Establishing Our Foundation of LGMD2I/R9
https://practicalneurology.com/programs/cme/establishing-our-foundation-of-lgmd2ir9/35588/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Addressing Alzheimer's Disease: Target 2025
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/addressing-alzheimers-disease-target-2025/30631/The Alzheimer's Association takes an in-depth look at the US National Plan to Address Alzheimer's Disease, which seeks to prevent and effectively treat Alzheimer's disease by 2025.SmartCare: How New Technologies Are Changing the Parkinson's Spectrum
https://practicalneurology.com/diseases-diagnoses/movement-disorders/smartcare-how-new-technologies-are-changing-the-parkinsons-spectrum/30472/News
https://practicalneurology.com/archives/2014-june/news/30653/A Transformational Era in Stroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/a-transformational-era-in-stroke-care/30221/The 2018 guidelines for treatment of acute ischemic stroke reflect great advances in patient care.News
https://practicalneurology.com/columns/practice-management/news/30596/POINT-COUNTERPOINT: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/point-counterpoint-natalizumab-extended-interval-dosing/30124/Optimism vs caution for using extended-interval dosing to prevent progressive multifocal leukoencephalopathy.